JP2015530094A - 対象の肝臓癌を診断する方法及び肝臓癌を診断するためのキット - Google Patents

対象の肝臓癌を診断する方法及び肝臓癌を診断するためのキット Download PDF

Info

Publication number
JP2015530094A
JP2015530094A JP2015533022A JP2015533022A JP2015530094A JP 2015530094 A JP2015530094 A JP 2015530094A JP 2015533022 A JP2015533022 A JP 2015533022A JP 2015533022 A JP2015533022 A JP 2015533022A JP 2015530094 A JP2015530094 A JP 2015530094A
Authority
JP
Japan
Prior art keywords
gene
hcc
subject
liver cancer
tnfaip3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015533022A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015530094A5 (enExample
Inventor
マン ホイ カム
マン ホイ カム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Singapore Health Services Pte Ltd
Original Assignee
Singapore Health Services Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Singapore Health Services Pte Ltd filed Critical Singapore Health Services Pte Ltd
Publication of JP2015530094A publication Critical patent/JP2015530094A/ja
Publication of JP2015530094A5 publication Critical patent/JP2015530094A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2015533022A 2012-09-21 2013-09-23 対象の肝臓癌を診断する方法及び肝臓癌を診断するためのキット Pending JP2015530094A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261704425P 2012-09-21 2012-09-21
US61/704,425 2012-09-21
PCT/SG2013/000414 WO2014046623A1 (en) 2012-09-21 2013-09-23 Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer

Publications (2)

Publication Number Publication Date
JP2015530094A true JP2015530094A (ja) 2015-10-15
JP2015530094A5 JP2015530094A5 (enExample) 2016-10-20

Family

ID=50341782

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015533022A Pending JP2015530094A (ja) 2012-09-21 2013-09-23 対象の肝臓癌を診断する方法及び肝臓癌を診断するためのキット

Country Status (7)

Country Link
US (1) US20150232943A1 (enExample)
EP (1) EP2898099A4 (enExample)
JP (1) JP2015530094A (enExample)
KR (1) KR20150058465A (enExample)
CN (1) CN104812914B (enExample)
SG (1) SG11201502089QA (enExample)
WO (1) WO2014046623A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101843173B1 (ko) * 2014-10-24 2018-03-29 씨비에스바이오사이언스 주식회사 혈관 내피 세포 성장인자 수용체 억제제에 대한 감수성 예측 방법
KR102116178B1 (ko) 2017-05-10 2020-05-27 서울대학교산학협력단 간암 고위험군의 간암 발병 모니터링 또는 진단용 바이오마커 및 그 용도
CN108048422A (zh) * 2017-11-30 2018-05-18 天津市湖滨盘古基因科学发展有限公司 一种gtp酶，imap家族成员7突变蛋白及其应用
CN110241198A (zh) * 2019-05-30 2019-09-17 成都吉诺迈尔生物科技有限公司 一种表征hHRD同源重组缺陷的基因组重组指纹及其鉴定方法
CN111610262A (zh) * 2020-05-19 2020-09-01 上海鹿明生物科技有限公司 一种用于肝胆疾病诊断的代谢标志物
WO2025111814A1 (zh) * 2023-11-28 2025-06-05 何牮 一种b细胞的生物标志物组及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060003327A1 (en) * 2002-03-21 2006-01-05 Anat Achiron Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
US20070148648A1 (en) * 2003-11-04 2007-06-28 Martin Dugas Method for distinguishing who classified aml subtypes
JP2009517064A (ja) * 2005-11-30 2009-04-30 アンスティテュ、ナショナル、ド、ラ、サント、エ、ド、ラ、ルシェルシュ、メディカル（アンセルム） 肝細胞癌腫分類および予後判定のための方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008138578A2 (en) * 2007-05-11 2008-11-20 Medical Prognosis Institute Methods, kits, and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
EP2352847B1 (en) * 2008-11-10 2014-01-08 The United States of America, as represented by The Secretary, Department of Health and Human Services Gene signature for predicting prognosis of patients with solid tumors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060003327A1 (en) * 2002-03-21 2006-01-05 Anat Achiron Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
US20070148648A1 (en) * 2003-11-04 2007-06-28 Martin Dugas Method for distinguishing who classified aml subtypes
JP2009517064A (ja) * 2005-11-30 2009-04-30 アンスティテュ、ナショナル、ド、ラ、サント、エ、ド、ラ、ルシェルシュ、メディカル（アンセルム） 肝細胞癌腫分類および予後判定のための方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BIOCHEM. BIOPHYS. RES. COM., 2011年, vol. 411, JPN6017022486, pages 586 - 592, ISSN: 0003745801 *
CANCER RES., 2006年, vol. 66, no. 12, JPN6017022483, pages 6129 - 6138, ISSN: 0003745802 *

Also Published As

Publication number Publication date
EP2898099A4 (en) 2016-05-25
KR20150058465A (ko) 2015-05-28
WO2014046623A1 (en) 2014-03-27
CN104812914A (zh) 2015-07-29
SG11201502089QA (en) 2015-06-29
EP2898099A1 (en) 2015-07-29
US20150232943A1 (en) 2015-08-20
CN104812914B (zh) 2020-07-24

Similar Documents

Publication Publication Date Title
US20220214345A1 (en) Colorectal cancer screening examination and early detection method
JP6401702B2 (ja) 炎症性肝疾患の診断のための方法および組成物
CN104812914B (zh) 诊断受试者中的肝癌的方法及诊断肝癌的试剂盒
US12391992B2 (en) Kit for early screening of liver cell cancer and preparation method and use thereof
Qiao et al. Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection
US10859573B2 (en) Nourin molecular biomarkers diagnose angina patients with negative troponin
JP3538381B2 (ja) 結腸癌を診断し、モニターし、そして病期決定する新規方法
TWI408370B (zh) 胰臟癌之血清生物檢測標誌及其應用
Block et al. The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop
CN116867911A (zh) 用于胃癌预防和早期发现的生物标志物特征
Farag et al. Studying the impact of Golgi protein 73 serving as a candidate biomarker in early diagnosis for hepatocellular carcinoma among Saudi patients
Han et al. Development and validation of a decision tree classification model for the essential hypertension based on serum protein biomarkers
JP6876301B2 (ja) 肝細胞がん患者の再発リスク予測を補助する方法、装置、コンピュータプログラム製品及びキット
EP4278187A1 (en) Method for the detection of lung cancer
JP2002515263A (ja) 前立腺がんを診断し、モニターし、そして病期決定する新規な方法
KR102863350B1 (ko) 간암 진단용 신규 혈액 바이오마커 itga6 및 이의 용도
El-Sharkawy et al. Circulating tumor cells in breast cancer: a step toward precision medicine for real-time monitoring of metastasis
Lee et al. Genomic and proteomic biomarkers for diagnosis and prognosis of hepatocellular carcinoma
JP2019050736A (ja) 血管炎の診断用バイオマーカー
CN102010903A (zh) Il-23在肝癌早期病变诊断中的应用
Mahmoud et al. The Determination of Alpha-fetoprotein, Golgi protein-73 and Glypican-3 Levels in Chronic Viral Hepatitis B Patients with Fibrosis in Baghdad Gastroenterology and Hepatology Hospital
US20250102521A1 (en) Informative biomarkers of portal hypertension
CN117947161A (zh) 一种诊断、检测、监测、预测肝癌预后的计算机系统和试剂盒
CN103487581A (zh) 血清dkk1在制备甲胎蛋白阴性肝细胞癌的诊断试剂中的用途
Kwon et al. Studying the Impact of Golgi Protein 73 Serving as a Candidate Biomarker in Early Diagnosis for Hepatocellular Carcinoma among Saudi Patients

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160831

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160901

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170620

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170920

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180227

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181002